Invitation to Submit Proposals Under Framework Agreements 2023/0304 - Medicines of Group 4: Blood; 2023/0481 - Various Medicines; 2023/0491 - Oncology and Immunomodulatory Medicines; 2023/0495 - Medicines for the Genitourinary System; 2024/0900 - Antiretroviral Medicines for HIV Infection Treatment; 2024/0961 - Various Medicines; 2025/1303 - Various Medicines; 2025/1367 - Medicines for the Digestive System; 2025/1428 - Antipsychotic Medicines

This tender invites proposals for the procurement of various categories of medicines under multiple framework agreements. The agreements include a wide range of medicinal products, specifically targeting group 4 medicines related to blood, oncology, immunomodulators, genitourinary system medications, antiretrovirals for HIV treatment, and other diverse pharmaceutical needs. The framework agreements span from 2023 to 2025, indicating a long-term procurement strategy aimed at ensuring a steady supply of essential medicines. Key requirements for bidders are likely to include compliance with regulatory standards, quality assurance protocols, and the ability to meet delivery timelines. The tender emphasizes the importance of providing high-quality pharmaceuticals to support healthcare initiatives. Interested parties are encouraged to review the specific details of each framework agreement to understand the scope of products required and the submission process. This initiative is crucial for maintaining healthcare services and addressing public health needs effectively.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 810.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.